Type 2 Diabetes Clinical Trial
Official title:
Effect of Virtual Reality Based Exercise Training v/s Aerobic Exercises on Cognitive Function in Adults With Type 2 Diabetes Mellitus.
The ain to this study was to determine the effects of Exergaming and Aerobic exercise on mild cognitive impairment (MCI) and random blood sugar levels (RBS) in adults with type 2 diabetes mellitus (T2DM) and to compare the effects between both treatments.This Randomized Control Trial (RCT) enrolled 33 diabetics to Aerobic group (AG) (n=18) and Exergaming training group (ER) (n=15) who completed the six weeks of aerobics or ER training. Aerobic group followed intervention using treadmill for 30 mins/day for 3 days/week maintaining intensity of 40-60% heart rate reserve (HRR). The ER group did physical activity using X-box 360 for 30 mins/day, 3 days/week. The cognitive testing included MMSE, MOCA, Trail-A/B and verbal fluency test (VF). The random blood sugar levels (RBS) of the participants were also monitored. Data was analyzed on IBM SPSS Statistics 20.
The American Diabetes Association define diabetes as a metabolic disorder characterized by
decreased production of insulin and/or the development of insulin resistance which results in
hyperglycemia. The most common types of DM are type 1 and type 2. Type 2 diabetes mellitus
(T2DM) is more commonly observed in adults and represents 90-95% cases worldwide. According
to WHO, Pakistan is ranked 7th among countries with high prevalence rate of T2DM. A review
done in December 2016 stated that the prevalence rate of T2DM in Pakistan is 11.77%. (Males
=11.20% /females=9.19%).
Diabetes mellitus is found to be associated with a vast majority of co-morbidities that have
devastating impact on the health and quality of life of the patients. Among diabetics the
development of cardiovascular dysfunctions is a well known cause of mortality and morbidity.
Around 80% diabetic populations develop the metabolic syndrome, characterized by the
development of insulin resistance along with hypertension, Dyslipidemia and visceral obesity.
Obesity is very commonly observed among diabetics and the occurrence of visceral adiposity
contributes to the increment of the pathogenesis of insulin resistance. Other co-morbidities
associated with diabetes are diabetic retinopathy, neuropathy, nephropathy, psychosocial
impairments and cognitive dysfunction.
It is well known that diabetes mellitus is found to be associated with many co-morbidities.
Recent evidences show that it is also a risk factor for the development of cognitive
impairment. Studies show that diabetics have a 1.2- to 1.5-fold greater rate of developing
decline in cognitive function compared to those without diabetes. A 15 year follow up study
done in Japan in 2011 also reported increased prevalence of dementia among the diabetics. It
is becoming evident that diabetes affects the nervous system causing diabetic encephalopathy
which results in the neuronal damage and loss contributing to cognitive dysfunction. A review
published in 2009 stated that mild to moderate cognitive declines were observed among
diabetics. Reduced performance was observed on the tests of multiple cognitive domains
including episodic memory, information processing speeds and task executive functioning. A
little decline was also observed on the tests concerning mental flexibility. It is becoming
evident from the data of epidemiological studies that there is strong association between
diabetes and increased risk of pathological changes in central nervous system resulting in
cognitive dysfunction and later on developing into dementia. A review states that it is
evident from the neurocognitive testing that cognitive decline should be listed among the
many diabetes associated complications. The factors like the end organ damage influenced by
hyperglycemia, vascular and neuronal damage, hypoglycemia and the presence of amyloid lesions
may be held responsible for the changes and damages to cerebral structure. Literature shows
that cognitive dysfunction is also related with the diabetes associated co-morbidities
including Increased obesity, Low muscle mass, depression, cardiovascular diseases, chronic
inflammation and cerebrovascular diseases.
Diet and exercise represent the initial treatment approaches in clinical practice to slow
progression of metabolic disturbance associated with prediabetes and to assist with
pharmacological treatment in established T2DM. Increased physical activity has clear
beneficial physiological effects for older adults with T2DM or glucose intolerance or insulin
resistance and more recently has been shown to benefit cognition as well.Epidemiological
evidence consistently links physical exercise with better cognitive performance, lower risks
for dementia, and reduced pathological changes in the central nervous system (CNS).
Experimental studies have also reported benefits of aerobic and resistance training on
cognitive function in older adults.
The trend towards using the virtual reality as a platform for rehabilitation among many
neurological deficits is increasing tremendously. Researches show that VR training may be
helpful in improving the physical, cognitive and emotional impairments faced by the patients
experiencing some neurological deficit. It has been seen that when patients following brain
insult after stroke are involved in VR related rehabilitation programs their functional
performance was improved. The improvements were seen in balance, walking speeds and mobility.
Although no trials have been done to our knowledge concerning the use of virtual reality and
cognitive dysfunctions in adults with T2DM but a variety of researches indicate that VR can
be useful in treating cognitive impairments. Undoubtedly VR training has potential to
simulate many real life or imaginary situations, hence providing the platform for more valid
and dynamic assessment and training. It also provides a constant environment with the
prospective for multiple repetitions of the same task to be assessed. Furthermore in contrast
to many conventional methods, VR-based assessment and training provides accurate performance
measurements and exact replays of task performance. Currently VR is being used as a
supportive intervention after brain damage to deal with multiple aspects of cognitive
impairments including memory impairment, executive dysfunctions, visio-spatial and attention
deficit. The use of VR brain damage rehabilitation is exceedingly expanding and will become
an important part of cognitive assessment and rehabilitation in future. Studies also show VR
as a beneficial tool for treating anxiety disorders.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |